- Grazoprevir/uprifosbuvir/ruzasvir, with/without ribavirin (RBV), is highly effective for clearing HCV after failure of NS5A inhibitor-containing all-oral direct-acting antiviral (DAA) regimens.
Why this matters
- Patients who fail DAAs have limited options.
You’ve reached the visitor articles limit
reserved for healthcare professionals
Register to read more
Already have an account? Login now